Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Scientists have isolated a plant enzyme that could be the key to mass-produced biofuels

Add as a preferred source on Google

Researchers are looking for a way to manufacture an environmentally friendly fuel, and they have turned to an unusual source: Botryococcus braunii, a common algae that is known for its hydrocarbon production. A team of international researchers announced this week that it has successfully isolated the enzyme responsible for this hydrocarbon production and are looking to use it to make biofuels en masse.

Biofuels are a form of hydrocarbons derived from biological processes sources. They require combustion and are not as environmentally friendly as solar or wind power, but they are compatible with our existing oil and gas-based fuel infrastructure

Recommended Videos

Botryococcus braunii is a pyramid-shaped algae found almost worldwide that is capable of producing hydrocarbons as part of its standard metabolism. These hydrocarbons account for up to 40 percent of the organism’s dry weight, and also are excreted outside the cell. Though capable of making hydrocarbons that can be used as fuel source, they don’t produce enough of it to be a suitable supply of commercial biofuels. Despite this limitation, scientists still are interested in studying the algae and exploring the mechanism by which it produces its hydrocarbons.

In a study published recently in Nature Communications, the researchers report their discovery of an enzyme called lycopaoctaene synthase, which is involved in oil production. Inside the slow growing Botryococcus braunii, lycopaoctaene synthase only produces a small yield of hydrocarbon, but it is capable of much more. Once the enzyme is inserted into a faster-growing organism, researchers can use the system to increase the rate of production of the hydrocarbon.

“Maybe if we can transfer the genetic information to make these oils into quicker-growing organisms like other algae that grow a lot quicker or a land plant that can produce large amounts of biomass, we can have them produce oil for us,” said author and scientist Timothy Devarenne who was part of the team of scientists from Texas A&M University, the University of Arizona, Japan Science and Technology, and China’s Biotechnology.

Kelly Hodgkins
Kelly's been writing online for ten years, working at Gizmodo, TUAW, and BGR among others. Living near the White Mountains of…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more